Partnering & Licensing

partnering2

Partnering With Us

TRIANNI partners with other companies interested developing therapeutic monoclonal antibodies by utilizing our proprietary platform – The Trianni Mouse. Licensing is available directly or through CROs for use in their antibody discovery solutions. Contact us for more information.

Discovery Partners

TRIANNI’s Discovery Partners include several medium-large pharma partners. Below is representative of those that are publicly announced.

Takeda-01
achaogen-01
merck-logo-01
innovent-01
sanofi-01
austrianni-01
FredHutch
gigagen-01
Immunomic-01
OPT-01
lakepharma-01
Symphogen-01
bluebird-01
Juno-01

Academic Agreements

Trianni, Inc holds licensing agreements with Massachusetts General Hospital,  Stanford University  and the  University of Alabama, Birmingham.